FFA
OGN icon

Fairfield Financial Advisors’s Organon & Co OGN Stock Holding History

Fairfield Financial Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$293 – 317
2022
Q3 		$293 Buy
13
+1
+8% +$30 ﹤0.01% 314
2022
Q2 		$419 Sell
12
-6
-33% -$210 ﹤0.01% 295
2022
Q1 		$640 Buy
+18
New +$616 ﹤0.01% 298

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fairfield Financial Advisors's OGN Position: Q4 2022 in Review

Fairfield Financial Advisors sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 13 shares — an estimated $293 sold.

Fairfield Financial Advisors first reported a position in OGN in Q1 2022 and held it in 3 quarters. The position peaked at $640 in Q1 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Fairfield Financial Advisors reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Fairfield Financial Advisors sold 13 Organon & Co shares in Q4 2022, an estimated $293.
  • Fairfield Financial Advisors first reported a position in Organon & Co in Q1 2022 and held it in 3 quarters.
  • Fairfield Financial Advisors's Organon & Co position peaked at $640 in Q1 2022.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Fairfield Financial Advisors's 13F filing for Q4 2022, filed 7 Oct 2024.